<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37745754</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2468-0427</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Infectious Disease Modelling</Title><ISOAbbreviation>Infect Dis Model</ISOAbbreviation></Journal><ArticleTitle>The impact of EV71 vaccination program on hand, foot and mouth disease in Zhejiang Province, China: A negative control study.</ArticleTitle><Pagination><StartPage>1088</StartPage><EndPage>1096</EndPage><MedlinePgn>1088-1096</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.idm.2023.09.001</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To estimate the potential causal impact of Enterovirus A71 (EV71) vaccination program on the reduction of EV71-infected hand, foot, and mouth disease (HFMD) in Zhejiang Province.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We utilized the longitudinal surveillance dataset of HFMD and EV71 vaccination in Zhejiang Province during 2010-2019. We estimated vaccine efficacy using a Bayesian structured time series (BSTS) model, and employed a negative control outcome (NCO) model to detect unmeasured confounding and reveal potential causal association.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We estimated that 20,132 EV71 cases (95% CI: 16,733, 23,532) were prevented by vaccination program during 2017-2019, corresponding to a reduction of 29% (95% CI: 24%, 34%). The effectiveness of vaccination increased annually, with reductions of 11% (95% CI: 6%, 16%) in 2017 and 66% (95% CI: 61%, 71%) in 2019. Children under 5 years old obtained greater benefits compared to those over 5 years. Cities with higher vaccination coverage experienced a sharper EV71 reduction compared to those with lower coverage. The NCO model detected no confounding factors in the association between vaccination and EV71 cases reduction.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">This study suggested a potential causal effect of the EV71 vaccination, highlighting the importance of achieving higher vaccine coverage to control the HFMD.</AbstractText><CopyrightInformation>© 2023 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Dashan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Lingzhi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, 310051, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Wanqi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ling</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, 310051, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Ziping</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, 310051, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jimin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, 310051, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Hualiang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Infect Dis Model</MedlineTA><NlmUniqueID>101692406</NlmUniqueID><ISSNLinking>2468-0427</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bayesian structure time series model</Keyword><Keyword MajorTopicYN="N">Enterovirus A71 (EV71) vaccine</Keyword><Keyword MajorTopicYN="N">Hand, foot, and mouth disease (HFMD)</Keyword><Keyword MajorTopicYN="N">Negative control outcome</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>5</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37745754</ArticleId><ArticleId IdType="pmc">PMC10514095</ArticleId><ArticleId IdType="doi">10.1016/j.idm.2023.09.001</ArticleId><ArticleId IdType="pii">S2468-0427(23)00083-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arnold B.F., et al. Brief report: Negative controls to detect selection bias and measurement bias in epidemiologic studies. Epidemiology. 2016;27(5):637–641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4969055</ArticleId><ArticleId IdType="pubmed">27182642</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodersen K.H., et al. Inferring causal impact using Bayesian structural time-series models. Annals of Applied Statistics. 2015;9(1):247–274.</Citation></Reference><Reference><Citation>Chang Y.K., Chen K.H., Chen K.T. Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: A review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development. Revista do Instituto de Medicina Tropical de Sao Paulo. 2018;60:e70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6223252</ArticleId><ArticleId IdType="pubmed">30427405</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y., et al. Epidemiological characteristics of hand, foot, and mouth disease clusters during 2016-2020 in Beijing, China. Journal of Medical Virology. 2022;94(10):4934–4943.</Citation><ArticleIdList><ArticleId IdType="pubmed">35655366</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z., et al. Assessing the vaccine effectiveness for hand, foot, and mouth disease in guangzhou, China: A time-series analysis. Human Vaccines &amp; Immunotherapeutics. 2021;17(1):217–223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7872061</ArticleId><ArticleId IdType="pubmed">32530733</ArticleId></ArticleIdList></Reference><Reference><Citation>Fireman B., et al. Influenza vaccination and mortality: Differentiating vaccine effects from bias. American Journal of Epidemiology. 2009;170(5):650–656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2728831</ArticleId><ArticleId IdType="pubmed">19625341</ArticleId></ArticleIdList></Reference><Reference><Citation>Flanders W.D., Strickland M.J., Klein M. A new method for partial correction of residual confounding in time-series and other observational studies. American Journal of Epidemiology. 2017;185(10):941–949.</Citation><ArticleIdList><ArticleId IdType="pubmed">28430842</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparrini A., Armstrong B. Time series analysis on the health effects of temperature: Advancements and limitations. Environmental Research. 2010;110(6):633–638.</Citation><ArticleIdList><ArticleId IdType="pubmed">20576259</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez G., et al. Enterovirus-associated hand-foot and mouth disease and neurological complications in Japan and the rest of the world. International Journal of Molecular Sciences. 2019;20(20)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6834195</ArticleId><ArticleId IdType="pubmed">31635198</ArticleId></ArticleIdList></Reference><Reference><Citation>Head J.R., et al. Early evidence of inactivated enterovirus 71 vaccine impact against hand, foot, and mouth disease in a major center of ongoing transmission in China, 2011-2018: A longitudinal surveillance study. Clinical Infectious Diseases. 2020;71(12):3088–3095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7819528</ArticleId><ArticleId IdType="pubmed">31879754</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., et al. Epidemiology of recurrent hand, foot and mouth disease, China, 2008-2015. Emerging Infectious Diseases. 2018;24(3):432–442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5823341</ArticleId><ArticleId IdType="pubmed">29460747</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson M.L., et al. Further evidence for bias in observational studies of influenza vaccine effectiveness: The 2009 influenza A(H1N1) pandemic. American Journal of Epidemiology. 2013;178(8):1327–1336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314269</ArticleId><ArticleId IdType="pubmed">23978527</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji T., et al. Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 2017. Biosafety and Health. 2019;1(1):32–40.</Citation></Reference><Reference><Citation>Li R., et al. An inactivated enterovirus 71 vaccine in healthy children. New England Journal of Medicine. 2014;370(9):829–837.</Citation><ArticleIdList><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., et al. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in henan, China, 2017-18: A test-negative case-control study. Lancet Child Adolesc Health. 2019;3(10):697–704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8713082</ArticleId><ArticleId IdType="pubmed">31375313</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsitch M., Jha A., Simonsen L. Observational studies and the difficult quest for causality: Lessons from vaccine effectiveness and impact studies. International Journal of Epidemiology. 2016;45(6):2060–2074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5841615</ArticleId><ArticleId IdType="pubmed">27453361</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsitch M., Tchetgen Tchetgen E., Cohen T. Negative controls: A tool for detecting confounding and bias in observational studies. Epidemiology. 2010;21(3):383–388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3053408</ArticleId><ArticleId IdType="pubmed">20335814</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., et al. Bayesian structural time series for biomedical sensor data: A flexible modeling framework for evaluating interventions. PLoS Computational Biology. 2021;17(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8412351</ArticleId><ArticleId IdType="pubmed">34424894</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopalco P.L., DeStefano F. The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines. Vaccine. 2015;33(13):1541–1548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4596394</ArticleId><ArticleId IdType="pubmed">25444788</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Q., et al. Analysis of epidemiological characteristics of notifiable diseases reported in children aged 0ق ؛14 Years from 2008 to 2017 in Zhejiang province, China. International Journal of Environmental Research and Public Health. 2019;16(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6352024</ArticleId><ArticleId IdType="pubmed">30634443</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson D.B., et al. Negative control outcomes and the analysis of standardized mortality ratios. Epidemiology. 2015;26(5):727–732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4763995</ArticleId><ArticleId IdType="pubmed">26172862</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott S.L., Varian H.R. Predicting the present with Bayesian structural time series. International Journal of Mathematical Modelling. 2014;5(1–2):4–23.</Citation></Reference><Reference><Citation>Shi X., Miao W., Tchetgen E.T. A selective review of negative control methods in epidemiology. Current Epidemiology Reports. 2020;7(4):190–202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118596</ArticleId><ArticleId IdType="pubmed">33996381</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski D.M., et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: Four observational studies from Canada. PLoS Medicine. 2010;7(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2850386</ArticleId><ArticleId IdType="pubmed">20386731</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofer T., et al. On negative outcome control of unobserved confounding as a generalization of difference-in-differences. Statistical Science. 2016;31(3):348–361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5322866</ArticleId><ArticleId IdType="pubmed">28239233</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi S., et al. Hand, foot, and mouth disease in China: Modeling epidemic dynamics of enterovirus serotypes and implications for vaccination. PLoS Medicine. 2016;13(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4755668</ArticleId><ArticleId IdType="pubmed">26882540</ArticleId></ArticleIdList></Reference><Reference><Citation>Vizzotti C., et al. Impact of a maternal immunization program against pertussis in a developing country. Vaccine. 2016;34(50):6223–6228.</Citation><ArticleIdList><ArticleId IdType="pubmed">27847175</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X. Chinese Center Disease Control Prevent; 2019. Study on the burden of hand, foot, and mouth disease and the effectiveness evaluation of the EV-A71 vaccination program in Beijing.</Citation></Reference><Reference><Citation>Wang J., et al. The changes in the epidemiology of hand, foot, and mouth disease after the introduction of the EV-A71 vaccine. Vaccine. 2021;39(25):3319–3323.</Citation><ArticleIdList><ArticleId IdType="pubmed">33994239</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H., et al. Trend of hand, foot, and mouth disease from 2010 to 2021 and estimation of the reduction in enterovirus 71 infection after vaccine use in Zhejiang Province, China. PLoS One. 2022;17(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9488823</ArticleId><ArticleId IdType="pubmed">36126038</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J., et al. The impact of enterovirus A71 vaccination program on hand, foot, and mouth disease in Guangdong, China: A longitudinal surveillance study. Journal of Infection. 2022;85(4):428–435.</Citation><ArticleIdList><ArticleId IdType="pubmed">35768049</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W., et al. Hand, foot, and mouth disease in China, 2008-12: An epidemiological study. The Lancet Infectious Diseases. 2014;14(4):308–318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., et al. Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine. Euro Surveillance. 2017;22(50)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5743100</ArticleId><ArticleId IdType="pubmed">29258646</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F., et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. New England Journal of Medicine. 2014;370(9):818–828.</Citation><ArticleIdList><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>